Individuals with detectable human papillomavirus (HPV)-16 in their mouthwash samples were 22 times more likely to develop oropharyngeal cancer (OPC) than those without the type of virus, according to findings of a new study.
Mounting research continues to show increased risk of cancer recurrence and death in obese individuals, but findings of a new study highlight the benefits of weight-loss interventions for overweight and obese cancer survivors.
New research shows that survivors of testicular cancer may have an increased burden of morbidity after being treated with cisplatin-based chemotherapy, with obesity, neuropathies, and tinnitus and hearing loss among the most prevalent late effects.
Breast reconstruction surgery has become an increasingly popular option among women following mastectomy, but a recent study has found that most women who opt for the procedure are ill-informed of the potential risks.
Despite national evidence- and consensus-based guidelines on posttreatment care, less than half of adolescents and young adults (AYAs) with Hodgkin lymphoma receive all of the recommended services within the first year after treatment, according to results of a pilot study being presented at the 2016 Cancer Survivorship Symposium.
Studies show that cost is a factor in patient adherence to their oral anticancer medications, but the financial burden of oral chemotherapy drugs is projected to still be too high for millions of patients even when the Medicare Part D coverage gap, or â€œdoughnut hole,â€ is fully closed.
The incidence of Hodgkin lymphoma (HL) in women typically precedes and covers prime childbearing years, but a new study has found that pregnancy does not increase the risk of relapse among women in remission.